IYSYX
Price
$18.70
Change
+$0.13 (+0.70%)
Updated
Dec 24 closing price
VSCIX
Price
$116.87
Change
+$0.97 (+0.84%)
Updated
Dec 24 closing price
Ad is loading...

IYSYX vs VSCIX

Header iconIYSYX vs VSCIX Comparison
Open Charts IYSYX vs VSCIXBanner chart's image
Delaware Ivy Smid Cap Core Fund
Price$18.70
Change+$0.13 (+0.70%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Index I
Price$116.87
Change+$0.97 (+0.84%)
VolumeN/A
CapitalizationN/A
IYSYX vs VSCIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IYSYX vs. VSCIX commentary
Dec 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IYSYX is a Buy and VSCIX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 167B vs. IYSYX (355M). VSCIX pays higher dividends than IYSYX: VSCIX (1.43) vs IYSYX (0.59). IYSYX was incepted earlier than VSCIX: IYSYX (21 years) vs VSCIX (27 years). IYSYX is a more actively managed with annual turnover of: 13.00 vs. VSCIX (12.00). IYSYX has a lower initial minimum investment than VSCIX: IYSYX (0) vs VSCIX (5000000). IYSYX annual gain was more profitable for investors over the last year : 15.84 vs. VSCIX (14.59). VSCIX return over 5 years is better than : 49.25 vs. IYSYX (-1.53).
IYSYXVSCIXIYSYX / VSCIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years27 years-
Gain YTD15.77114.750107%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets355M167B0%
Annual Yield % from dividends0.591.4342%
Returns for 1 year15.8414.59109%
Returns for 3 years-8.3310.04-83%
Returns for 5 years-1.5349.25-3%
Returns for 10 years5.63115.705%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USEG1.530.04
+2.68%
US Energy Corp
ON67.901.27
+1.91%
ON Semiconductor Corp
AMTX2.630.04
+1.54%
Aemetis
ARDX4.640.06
+1.31%
Ardelyx
APLS33.320.11
+0.33%
Apellis Pharmaceuticals